L C B Logo (EUIPO, 12/16/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark L C B was filed as Figurative mark on 12/16/2024 at the European Union Intellectual Property Office. The current status of the mark is "Application published".
Logodesign (Wiener Klassifikation)
#Letter 'B' #Letter 'C' #Letter 'L'
| Trademark form | Figurative mark |
| File reference | 019120402 |
| Application date | December 16, 2024 |
| Publication date | January 14, 2025 |
Trademark owner
10, Gukjegwahak 10-ro, Yuseong-gu,
34002 Daejeon
KR
34002 Daejeon
KR
Trademark representatives
93 Akti Miaouli, 1st Floor
185 38 Piraeus
GR
goods and services
5
Vaccines; food supplements; vitamin preparations; crude drugs; nutraceuticals for use as a dietary supplement; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations; syrups for pharmaceutical purposes; lozenges for pharmaceutical purposes; cachets for pharmaceutical purposes; chemico-pharmaceutical preparations; antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drugs for medical purposes; medical preparations, especially antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; pharmaceutical compositions; extracts of medicinal plants; pharmaceuticals; medicines for human purposes; pharmaceutical products; antibiotics; anti-cancer preparations; mixed vitamin preparations; chemotherapeutics; pharmaceutical preparations for treatment of rare diseases
ID: 11019120402